Ann Regan works as a family office investor at Gilead Group. The firm's known portfolio counts 3 companies.
Is Ann Regan a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Affiliated funds' portfolios
Affiliated at Gilead Group, whose known portfolio counts 3 companies
- Hookipa Pharma
- PenPath
- Agilis Systems
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Drug Discovery and Pharma. Startups operating in these areas may find Ann Regan relevant.
Stage-wise, the deals at Gilead Group cluster around Growth, Seed and Series B rounds.
The firm portfolio and the focus above give founders context on whether Ann Regan matches their raise.
Colleagues at Gilead Group
Frequently asked questions
Who is Ann Regan?
Ann Regan is a family office investor based in St Louis, Missouri, United States, listed at Gilead Group. The known portfolio of that firm counts 3 companies. That portfolio belongs to the firm, not to Ann Regan personally.
What does Ann Regan invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery and Pharma. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Ann Regan invest at?
Gilead Group appears in Growth, Seed and Series B rounds across its known deals, and Ann Regan is listed there. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Ann Regan listed at?
Ann Regan is listed at Gilead Group. 2 other people in the database share a firm with Ann Regan.
How do I contact Ann Regan?
An email address, a phone number and a LinkedIn page are on file for Ann Regan. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal